Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Recordati's 2013 sales performance.

Italian pharma market set for continued downturn

Italian pharma market set for continued downturn This shift would help reduce the growing healthcare budget deficit, while hurting branded pharmaceutical companies operating in Italy - both domestic like Menarini and Recordati, as well as major multinationals.”.

Pharma deals during December 2012

Pharma deals during December 2012 Similarly Lundbeck is likely to get at least three years gross profit from the deal to divest to Recordati a range of rare disease products sold mainly in the US. ... 115. Lundbeck / Recordati. Product acquisition. Rare disease products. 100. Kent / DCC.

Interview: Giovanni Recordati

Interview: Giovanni Recordati The chairman and CEO of Recordati tells Linda Banks his plans for company expansion. ... Turkey is now our third largest market after Italy and France,” Recordati asserts.

Dermatology developments

Phase II. 275. Recordati/Frik Ilac (a). Acquires Turkish prescription pharmaceutical distributor with sales of 62m.

Interview: Jorge Gallardo, Almirall

Interview: Jorge Gallardo, Almirall The year's sales evolution has benefited from the launches of new products Silodyx (for benign prostatic hyperplasia, licence from Recordati)  and Conbriza  (for osteoporosis, in co-promotion with Pfizer) in

[ Previous 5 results ] 1 2 3 4 5 6 7 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....